Investigators evaluated de-identified clinical data from 2,108,676 patients to assess the prevalence of acute PAs among patients with psoriasis.
#Psoriasis #ClinicalResearch hubs.ly/Q04CcDp90
Case report: A 49-year-old woman was seen by the dermatology consult service with inflammatory, tender, indurated, pink plaques on the upper extremities, as well as an edematous right upper extremity (**Figure 1**).
#DermDx #ClinicalResearch hubs.ly/Q04CcD4v0
Myth: Nail Findings in Alopecia Areata are Clinically Insignificant. Nail involvement in alopecia areata may provide valuable clues about disease severity and prognosis.
#AlopeciaAreata #DermatologyEducation hubs.ly/Q04CcC_h0
Researchers examined the experiences, preferences, and perspectives of patients and DCPs regarding the use of telemedicine for patients with psoriasis or AD receiving systemic therapy.
#Psoriasis #ClinicalResearch hubs.ly/Q04CcD010
In focus: The prevalence of contact allergy to specific allergens may fluctuate with time and reflects changes in the marketing and consumerism of today’s world.
#ContactDermatitis #DermatologyEducation hubs.ly/Q04CcD030
Myth: There is no Treatment for Alopecia Areata. Advances in alopecia areata treatment have transformed patient care.
#AlopeciaAreata #DermatologyEducation hubs.ly/Q04CcDpf0
The growing use of biologic and oral targeted therapies has expanded treatment options for psoriasis and atopic dermatitis, including among patients with cancer-related risks.
#Psoriasis #ClinicalResearch hubs.ly/Q04CcD4y0
In focus: For decades, dermatologists have relied on clinical examination, dermoscopy, and histopathology to evaluate disease above and below the skin surface.
#DermTech #DermatologyEducation hubs.ly/Q04CcC_k0
Myth: Alopecia Areata is Contagious. Misconceptions about alopecia areata being contagious continue to fuel stigma.
hubs.ly/Q04CcGtN0
#AlopeciaAreata #DermatologyEducation
Melanoma staging doesn't tell the whole story.
DecisionDx-Melanoma (31-GEP) may help refine recurrence risk, SLNB discussions, and surveillance planning.
Explore molecular risk assessment in melanoma care.
hubs.ly/Q04BP2Pq0
#Melanoma #DermTwitter
🚨 FDA approves baricitinib for adolescents (12+) with severe AA.
Phase 3 results:
✔️ 42% achieved SALT ≤20 (4 mg)
✔️ 37% achieved SALT ≤10
✔️ Brow & lash regrowth improved
A major step for pediatric AA. 🔗
#DermTwitter #AlopeciaAreata #FDAApproval
Dermatomyositis is changing.
✔️ First FDA-approved oral therapy
✔️ Treat-to-target mindset
✔️ Earlier diagnosis + multidisciplinary care
Time to rethink disease control 🔗
hubs.ly/Q04xNh890
#DermTwitter #Dermatomyositis
Derm update: Myth Buster: Family History Is Required to Develop Alopecia Areata. Many patients develop alopecia areata without a family history—genetics is only part of the story. #AlopeciaAreata #Genetics hubs.ly/Q04qHqs00
Clinical takeaway: The Growing Role of Artificial Intelligence in Psoriasis Care. AI-enabled diagnostics and decision support are becoming increasingly relevant to psoriasis management. #Psoriasis #ArtificialIntelligence hubs.ly/Q04qJ4ZK0
Worth reading: Myth Buster: Steroids Are the Only Effective Treatment for Alopecia Areata. JAK inhibitors and emerging therapies are expanding the alopecia areata treatment toolbox. #AlopeciaAreata #JAKInhibitors hubs.ly/Q04qJ2G50
Myth check: Atypical Pityriasis Rosea. Atypical distribution and overlapping dermatitis make clinicopathologic correlation essential. #PityriasisRosea #CaseReport hubs.ly/Q04qJ3VC0
New: Myth Buster: Once a Patient Loses All Their Hair, Treatment Won’t Work. Severe alopecia areata can still respond to treatment—even after extensive hair loss. #AlopeciaAreata #HairRegrowth hubs.ly/Q04qJ82p0
What to know: Candidate Biomarkers Associated With T-Cell Infiltration in Psoriasis. Three candidate biomarkers may offer new insight into T-cell activity in psoriasis. #Psoriasis #Biomarkers hubs.ly/Q04qJ2gl0
Quick read: Clinical Tip: Standardize Before-and-After Photography. Consistent photography makes longitudinal comparisons more useful and more credible. #ClinicalTips #MedicalPhotography hubs.ly/Q04qHslX0
Evidence spotlight: Dual Th17/Type 2 Immune Signature in Taiwanese Patients With Psoriasis. Transcriptomic findings highlight molecular heterogeneity across populations with psoriasis. #Psoriasis #Th17 hubs.ly/Q04qJ1Gq0
